-
US FDA Approves Cimzia for Treatment of Adults with Active Ankylosing spondylitis
It is fortunate that the US Food and Drug Administration (FDA) have expediently approved UCB’s Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis (AS). This ameliorated development came when FDA successfully issued a Complete Response Letter relating to the supplemental Biologics …
-
Potential New Drug for Some Patients with Treatment-Resistant Lung Cancer
In a recent AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics there was investigational drug AZD9291, a third-generation EGFR inhibitor which illustrated promise in preclinical studies. It also offered trusted hope for patients with advanced lung cancers which might have become resistant to existing …
-
New Class of Drug Targets Heart Disease
The global pharma community appreciates the new class of drug which targets heart disease. The sources convey that the potent researchers had successfully developed a synthetic peptide which could be the first in a new class of drugs to treat heart disease, high blood pressure …
-
Aging Tumor Cells May Be an Effective Cancer Treatment
In a major breakthrough of effective Cancer treatment the potent scientists have professionally illustrated that diffuse of large B-cell lymphoma (DLBCL) may be susceptible to treatment. It is then by re-activating the normal aging program in tumor cells can no longer divide. This potent findings …
-
Statin, Osteoporosis Drug Combo May Help Treat Parasitic Infections
It is happy to know that Statin and osteoporosis drug combo may help to treat parasitic infections. This was achieved and recently discovered that a potent combination of two commonly prescribed drugs utilized to treat high cholesterol and osteoporosis. It would cinch serve as the …
-
Collegium Gets US Patent Covering Oxycodone DETERx ER opioid product
In today’s major headlines was that the Collegium Pharmaceutical, Inc., a popular pharmaceutical company, has successfully acknowledged US patent from the Patent and Trademark Office (USPTO). More over it is reported that for issuance as a new patent by the USPTO. These two patents relate …
-
Drug Activates Virus Against Cancer
It is reported that Parvoviruses cause no baleful in humans, but they could attack and kill cancer cells. It was in 1992, where scientists at the German Cancer Research Centre (Deutsches Krebsforschungszentrum, DKFZ) have been successfully studying these viruses with the target of developing a …
-
PPMD, Sarepta Join Forces on Genetic Testing Programme for DMD patients
The major news broke out in the field of Genetic testing programme as Parent Project Muscular Dystrophy (PPMD) and Sarepta Therapeutics, Inc. have successfully started a nationwide programme from PPMD to help individuals with Duchenne muscular dystrophy (DMD) in professionally accessing genetic testing. This persuasive …
-
Adaptive Bio Receives US patent for Nxt Generation Immunosequencing field
There is good news in the field of immunosequencing where Adaptive Biotechnologies Corporation, a potent pioneer in the field of genomic immune profiling, has successfully received a notice of allowance in US Patent Application titled “Method of Measuring Adaptive Immunity”. It is therefore expediently licensed …
-
How important is Implatable Cardioverter Defibrillator
ICD’s are invaluable for treating patients with VT. These devices can be programmed to deliver different types of therapy for several kinds of VT, such as anti-tachycardia pacing or direct current shocks ranging from 1-40. When a milder treatment fails to convert a tachycardia, the …
ONLINE COMMUNITY PORTAL FOR PHARMACEUTICAL INDUSTRY IN INDIA.
